Skip to main content

NCT00236873 - Double-Blind Parallel Comparison of Topiramate 200 mg Twice Daily to Placebo in Patients With Refractory Partial Epilepsy

Double-Blind Parallel Comparison of Topiramate 200 mg Twice Daily to Placebo in Patients With Refractory Partial Epilepsy


Data Specification

Not Available


Annotated CRF

Not Available

Product Info

Generic Name
Topiramate
Product Name
TOPAMAX®
Therapeutic Area
Nervous System Diseases
Enrollment
47
% Female
14.9%
% White
100.0%
Product Class
Anticonvulsants
Sponsor Protocol Number
Y1 (CC2604-C-101)
Data Partner
Johnson & Johnson
Condition Studied
Epilepsy
Mean/Median Age (Years)
34.0

Supporting Documentation

Collected Datasets
Protocol with Amendments
Study Phase 
2

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.